ISIN
MKREPL101013
Ticker
None
Sector
Sub-Industry
Country
North Macedonia
Year Founded
1945
Replek AD Skopje is a Macedonian company operating in the pharmaceutical sector. It manufactures generic drugs in various pharmaceutical categories, such as oral dosage forms: Tablets, capsules and oral solutions, as well as medicines for topical use: creams and ointments.
Worldwide
Type | Document | Details | Language | Filing Date | File Number |
---|
Access comprehensive European stock market filings data through a single, powerful API.
700k+
filings covered
18
European countries
15min
max latency
1 API
for all filings
Limited spots available. Join now!
We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.
MKREPL101013
ABVX
Sector
Health Care
Country
France
ISIN
FR0012333284
Founded
Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections …
ADXN
Sector
Health Care
Country
Switzerland
ISIN
CH0029850754
Founded
2002
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally …
AEGIR
Sector
Health Care
Country
Sweden
ISIN
SE0014401121
Founded
2019
AegirBio is a Swedish diagnostics company that was founded to offer tests to monitor and optimize the dosage of biological …
None
Sector
Health Care
Country
North Macedonia
ISIN
MKALKA101011
Founded
1936
Alkaloid AD Skopje is a company which more than eight and a half decades, has been operating in the field …
ATB
Sector
Health Care
Country
Romania
ISIN
ROATBIACNOR9
Founded
1955
The leading manufacturer of generic drugs in Romania, Antibiotice SA was founded in December 1955. The company was listed on …
AZN
Sector
Health Care
Country
United Kingdom
ISIN
GB0009895292
Founded
1999
We are a global, science-led, patient-focused pharmaceutical company. We are tireless in seeking to realise the potential of what science …
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.